Cyclica announces close of Series A2 financing round

July 26, 2017

On July 26, 2017, Cyclica Inc. announced that it had completed a $2.25 million Series A2 financing, an extension of the $2.4 million Series A1 financing round that closed in September 2016. The syndicated investment group was led by GreenSky Accelerator Fund II, with co-investment by Epic Capital, Uni-Innovate Group, HH&E Ventures, and new and existing private investors.

Cyclica helps pharmaceutical companies navigate the drug discovery pipeline by assessing the safety and efficacy of drugs.

Miller Thomson advised Cyclica in this financing with a team that included Jennifer Bishop, Mack Hosseinian and Luigi Valente.